BIOWEG GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BIOWEG GmbH - overview
Established
2019
Location
Niedersachsen, -, Germany
Primary Industry
Biotechnology
About
Based in Germany, BIOWEG GmbH operates as a biotechnology firm focused on developing sustainable, bio-based ingredients to replace traditional petroleum and acrylic-based coatings in various industries. BIOWEG GmbH specializes in the production of bio-based ingredients. Founded in 2019 in Germany, the company has undergone strategic pivots, including expanding its product offerings. The founders, Prateek Mahalwar and Srinivas Karuturi, aim to address environmental challenges through innovative solutions.
IIn July 2025, BIOWEG GmbH raised EUR 16 million in series A funding led by investor European Innovation Council, with participation from other investors NBank, Ginkgo BioWorks, Inc. , BonVenture, and Axeleo. Individual investors also participated in the round. Their product lineup includes Rheoweg as a biodegradable alternative to microplastics in personal care, Agriweg as an agricultural coating, and Hydroweg for the food industry.
These products are engineered to mitigate environmental pollution and health risks associated with conventional materials and are targeted at manufacturers in Europe and North America. BIOWEG generates revenue through direct sales to B2B clients including manufacturers and distributors in relevant sectors. Their model focuses on bulk transactions and long-term partnerships, promoting the use of their eco-friendly products like Rheoweg and Agriweg, which meet increasing consumer demands for sustainable solutions. In January 2026, BIOWEG GmbH raised EUR 16 million in series A funding from unspecified investors.
The company aims to accelerate the development of a sustainable and bio-based Rare Earth Element recovery platform in collaboration with TU Berlin.
Current Investors
BONVENTURE, Ginkgo BioWorks, Inc., Axeleo
Primary Industry
Biotechnology
Sub Industries
Beauty & Hygiene, Bioinformatics, Biotechnology
Website
www.bioweg.com
Verticals
E-commerce
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.